<h3>Gainers</h3>
<ul>
<li>PACS Group (NYSE:PACS) stock rose 17.6% to $37.5 during Tuesday's pre-market session. The company's market cap stands at $5.0 billion. As per the press release, Q1 earnings came out yesterday. </li>
<li>Akari Therapeutics (NASDAQ:AKTX) shares moved upwards by 16.31% to $5.99. The company's market cap stands at $184.0 million. </li>
<li>Macrogenics (NASDAQ:MGNX) stock increased by 16.27% to $3.43. The market value of their outstanding shares is at $187.4 million. </li>
<li>USBC (AMEX:USBC) stock increased by 12.69% to $0.57. The market value of their outstanding shares is at $197.1 million. </li>
<li>Phio Pharmaceuticals (NASDAQ:PHIO) shares rose 10.18% to $1.19. The market value of their outstanding shares is at $12.5 million. As per the press release, Q1 earnings came out 3 days ago. </li>
<li>Dyadic International (NASDAQ:DYAI) stock rose 9.08% to $0.79. The company's market cap stands at $26.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>WORK Medical Tech Gr (NASDAQ:WOK) shares decreased by 45.7% to $2.13 during Tuesday's pre-market session. </li>
<li>CEL-SCI (AMEX:CVM) stock decreased by 26.25% to $1.04. The company's market cap stands at $11.9 million. </li>
<li>Pomdoctor (NASDAQ:POM) stock decreased by 22.69% to $0.11. The market value of their outstanding shares is at $17.6 million. </li>
<li>China Pharma Holding (AMEX:CPHI) shares decreased by 21.78% to $0.42. The company's market cap stands at $2.6 million. </li>
<li>Organigram Global (NASDAQ:OGI) shares fell 16.02% to $1.1. The market value of their outstanding shares is at $184.2 million. As per the news, the Q2 earnings report came out today. </li>
<li>Ensysce Biosciences (NASDAQ:ENSC) shares decreased by 14.88% to $0.33. The market value of their outstanding shares is at $3.5 million. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MGNX

USBC

In Tuesday's pre-market session, PACS Group saw a significant gain of 17.6%, reaching $37.5, with a market cap of $5.0 billion. Other notable gainers included Akari Therapeutics (+16.31%), Macrogenics (+16.27%), and USBC (+12.69%). Conversely, WORK Medical Tech experienced a sharp decline of 45.7%, followed by CEL-SCI (-26.25%) and Pomdoctor (-22.69%). Overall, the session highlighted substantial movements in health care stocks, influenced by recent earnings reports.

benzinga_article

Macrogenics

WORK Medical Tech

CEL-SCI

PACS

Pomdoctor

Akari Therap

VG Health

VanEck Biotech ETF

Invesco Biotechnology & Genome ETF

Ark Genomic Revolution ETF

iShares Global Healthcare

Proshares Ultra Nasdaq Biotech

iShares US Pharma

Direxion S&P Biotech Bull 3X

ALPS Medical Breakthrough

SPDR S&P Health

First Trust NYSE Arca Biotech Index Fd

iShares Biotechnology ETF

iShares US Healthcare Providers

Health Care Select Sector SPDR

iShares US Medical Devices

SPDR S&P Health Equip

SPDR S&P Biotech

Invesco Nasdaq Biotechnology ETF

Phio Pharmaceuticals

Dyadic

China Pharma

Organigram

Ensysce Biosciences

Ensysce Biosciences - CW22

12 Health Care Stocks Moving In Tuesday's Pre-Market Session